Inventor · disambiguated record
Gege Xu
Also filed as: XU GEGE
2 granted patents·7 pending applications·0 citations·filing 2020–2023
27Inventor score
Files withVENN BIOSCIENCES CORP9
Top patents by PatentIndex Score
9 records- 0165US12287342B2Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)VENN BIOSCIENCES CORP·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 0258US11774459B2Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)VENN BIOSCIENCES CORP·Filed 2021·Granted Oct 3, 2023·0 cites·21 claims
- 0354US2025087363A1Predicting sarcoma treatment response using targeted quantification of site-specific protein glycosylationVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 0452US2025189534A1Sample preparation for glycoproteomic analysis that includes diagnosis of diseaseVENN BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 0548US2023055572A1Biomarkers for diagnosing ovarian cancerVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 0648US2025149121A1Detection of peptide structures for diagnosing and treating sepsis and covidVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 0747US2023065917A1Biomarkers for diagnosing ovarian cancerVENN BIOSCIENCES CORP·Filed 2021·Application pending·0 cites
- 0845US2022310230A1Biomarkers for determining an immuno-onocology responseVENN BIOSCIENCES CORP·Filed 2022·Application pending·0 cites
- 0937US2022139499A1Biomarkers for diagnosing ovarian cancerVENN BIOSCIENCES CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gege Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →